Mounjaro 7.5 mg: Is This the Right Dose for You?

What the 7.5 mg dose actually represents in the treatment plan

The licensed tirzepatide schedule is built around gradual escalation, and 7.5 mg occupies a specific position: it follows the 5 mg dose and precedes 10 mg. The pattern is typically one pen at each strength before moving up, though prescribers may hold a dose longer if the body is still adjusting. There is a useful overview of where each strength sits on the Mounjaro dose overview page, which puts the full range in context.

The 2.5 mg starting dose is purely about tolerability — its job is to introduce your system to tirzepatide gently, not to drive weight loss. By the time most people reach 7.5 mg, the medicine's appetite-regulating effects are more established. This is also the dose at which some people find they can comfortably hold for a period, particularly if gastrointestinal side effects have not fully settled at the speed they expected.

One practical check that takes under a minute: before your injection each week, glance at the pen's label to confirm the strength printed there matches the dose your prescriber has approved. Pen designs look similar across the range, and verifying the number takes seconds but removes any doubt.

According to the NHS tirzepatide medicines page, doses are increased in steps with at least four weeks between each increase; your prescriber will not move you up sooner than that.

Moving from 5 mg to 7.5 mg: the decision your prescriber is making

The move from 5 mg to 7.5 mg is not automatic. A prescriber considers several things: whether gastrointestinal symptoms have settled, whether the previous dose was well tolerated over its full four weeks, and whether continuing at the current strength still makes clinical sense. At nume, a GPhC-registered Independent Prescriber reviews your information personally before any repeat or dose change, a real clinician looks at your case, not software.

If you are thinking about what this transition involves, the 5 mg to 7.5 mg Mounjaro page covers that specific step in detail, including what evidence of progress is typically reviewed.

People sometimes ask whether they can stay at 7.5 mg long term rather than continuing to escalate. The clinical answer is: it depends. Some people reach a weight loss plateau at a given dose and their prescriber will discuss going higher; others are tolerating and benefiting from the current dose and the prescriber may see no clinical reason to push further immediately. The goal is the highest dose you tolerate well, up to the 15 mg maximum. That decision belongs to the prescriber, not the dose schedule on a chart.

It is also worth knowing that the Mounjaro 5 mg page explains what to expect from that dose, which gives useful context for understanding how 7.5 mg builds on it; you can also read about Mounjaro 5.0 mg specifically if you want detail on that exact strength before considering the step up.

Side effects to be aware of at this dose

The side-effect profile at 7.5 mg mirrors the pattern seen across the tirzepatide range: nausea, loose stools, constipation, indigestion, fatigue and occasional headache are the most commonly reported. The week after a dose increase tends to be when these feel most noticeable, with most people finding they ease off over the following fortnight as the body adapts.

Injection-site reactions (mild redness, itching or a small lump) are also possible. Rotating the injection site between the abdomen, thigh and upper arm with each weekly dose helps reduce this, and our Mounjaro 7.5 mg pen page covers the practical details of using the device correctly. The patient information leaflet that comes with each pen lists the full side-effect profile and should be your reference for anything specific to your situation.

The NICE appraisal of tirzepatide (TA1026) notes that the clinical evidence underpinning tirzepatide's approval involved thousands of adults in the SURMOUNT trial programme; side-effect data across that population inform the guidance prescribers follow today.

A small number of people experience more serious symptoms. Severe stomach pain that radiates to the back (particularly if it persists) needs prompt medical attention, as pancreatitis, though uncommon, is a recognised risk with GLP-1 class medicines. If something feels wrong, contact a healthcare professional rather than waiting until your next review.

Getting the 7.5 mg dose through a regulated UK route

Mounjaro is a prescription-only medicine in the UK, which means the only legal way to obtain any strength (including 7.5 mg) is following a clinical assessment by a qualified prescriber. Buying pens through unverified online sellers or social media carries real risks; the MHRA has confirmed large seizures of fake weight-loss pens, some containing entirely different substances. Any pharmacy supplying it should be verifiable on the GPhC register.

For a broader picture of how Mounjaro fits into a supervised weight-loss plan, the Mounjaro overview page covers the treatment in full. If you want to understand what the cost of private treatment typically looks like, the weight-loss treatments page sets out what is included in one transparent price.

When you are ready to explore whether tirzepatide is suitable for you, speak to our prescribers through a free consultation, reviewed the same day by a named GPhC-registered clinician.